Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

NCT04045405 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cardior Pharmaceuticals GmbH